Stereotaxis Net Income
| STXS Stock | USD 1.99 0.03 1.49% |
As of the 15th of February 2026, Stereotaxis has the Risk Adjusted Performance of (0.09), variance of 13.99, and Coefficient Of Variation of (849.75). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stereotaxis, as well as the relationship between them. Please validate Stereotaxis coefficient of variation and value at risk to decide if Stereotaxis is priced more or less accurately, providing market reflects its prevalent price of 1.99 per share. Please also confirm Stereotaxis jensen alpha, which is currently at (0.53) to double-check the company can sustain itself at a future point.
Stereotaxis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.2797 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -27.7 M | -29 M | |
| Net Loss | -27.7 M | -29 M | |
| Net Loss | -22.6 M | -23.7 M | |
| Net Loss | (0.25) | (0.27) |
Stereotaxis | Net Income | Build AI portfolio with Stereotaxis Stock |
The evolution of Net Income for Stereotaxis provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Stereotaxis compares to historical norms and industry peers.
Latest Stereotaxis' Net Income Growth Pattern
Below is the plot of the Net Income of Stereotaxis over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Stereotaxis financial statement analysis. It represents the amount of money remaining after all of Stereotaxis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Stereotaxis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stereotaxis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (24.05 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Stereotaxis Net Income Regression Statistics
| Arithmetic Mean | (16,775,638) | |
| Geometric Mean | 9,709,083 | |
| Coefficient Of Variation | (99.36) | |
| Mean Deviation | 12,229,928 | |
| Median | (9,549,116) | |
| Standard Deviation | 16,668,962 | |
| Sample Variance | 277.9T | |
| Range | 68.9M | |
| R-Value | (0.03) | |
| Mean Square Error | 296.1T | |
| R-Squared | 0.0009 | |
| Significance | 0.91 | |
| Slope | (99,030) | |
| Total Sum of Squares | 4445.7T |
Stereotaxis Net Income History
Other Fundumenentals of Stereotaxis
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Stereotaxis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Stereotaxis is extremely important. It helps to project a fair market value of Stereotaxis Stock properly, considering its historical fundamentals such as Net Income. Since Stereotaxis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Stereotaxis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Stereotaxis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Stereotaxis introduce new products? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth (0.19) | Return On Assets | Return On Equity |
The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stereotaxis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Stereotaxis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Stereotaxis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stereotaxis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stereotaxis.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Stereotaxis on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Stereotaxis or generate 0.0% return on investment in Stereotaxis over 90 days. Stereotaxis is related to or competes with Sanara Medtech, NeoGenomics, Exagen, MDxHealth, Quanterix Corp, Arcturus Therapeutics, and Humacyte. Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the inter... More
Stereotaxis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stereotaxis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stereotaxis upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 16.89 | |||
| Value At Risk | (6.43) | |||
| Potential Upside | 4.69 |
Stereotaxis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stereotaxis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stereotaxis' standard deviation. In reality, there are many statistical measures that can use Stereotaxis historical prices to predict the future Stereotaxis' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.33) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stereotaxis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Stereotaxis February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.32) | |||
| Mean Deviation | 2.76 | |||
| Coefficient Of Variation | (849.75) | |||
| Standard Deviation | 3.74 | |||
| Variance | 13.99 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.33) | |||
| Maximum Drawdown | 16.89 | |||
| Value At Risk | (6.43) | |||
| Potential Upside | 4.69 | |||
| Skewness | (0.66) | |||
| Kurtosis | 2.47 |
Stereotaxis Backtested Returns
Stereotaxis owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0165, which indicates the firm had a -0.0165 % return per unit of risk over the last 3 months. Stereotaxis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stereotaxis' Coefficient Of Variation of (849.75), variance of 13.99, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The entity has a beta of 1.36, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Stereotaxis will likely underperform. At this point, Stereotaxis has a negative expected return of -0.0524%. Please make sure to validate Stereotaxis' coefficient of variation, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if Stereotaxis performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.06 |
Virtually no predictability
Stereotaxis has virtually no predictability. Overlapping area represents the amount of predictability between Stereotaxis time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stereotaxis price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Stereotaxis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Stereotaxis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Stereotaxis reported net income of (24.05 Million). This is 107.05% lower than that of the Health Care Equipment & Supplies sector and 124.13% lower than that of the Health Care industry. The net income for all United States stocks is 104.21% higher than that of the company.
Stereotaxis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stereotaxis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stereotaxis could also be used in its relative valuation, which is a method of valuing Stereotaxis by comparing valuation metrics of similar companies.Stereotaxis is currently under evaluation in net income category among its peers.
Stereotaxis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Stereotaxis from analyzing Stereotaxis' financial statements. These drivers represent accounts that assess Stereotaxis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Stereotaxis' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 468.5M | 157.4M | 141.2M | 194.2M | 174.8M | 113.1M | |
| Enterprise Value | 435.8M | 154.7M | 126.9M | 188.0M | 169.2M | 112.0M |
Stereotaxis Fundamentals
| Return On Equity | -1.7 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (0.79) % | ||||
| Operating Margin | (0.70) % | ||||
| Current Valuation | 188.86 M | ||||
| Shares Outstanding | 93.32 M | ||||
| Shares Owned By Insiders | 29.52 % | ||||
| Shares Owned By Institutions | 47.15 % | ||||
| Number Of Shares Shorted | 2.7 M | ||||
| Price To Earning | 21.61 X | ||||
| Price To Book | 30.09 X | ||||
| Price To Sales | 6.18 X | ||||
| Revenue | 26.92 M | ||||
| Gross Profit | 15.96 M | ||||
| EBITDA | (23.77 M) | ||||
| Net Income | (24.05 M) | ||||
| Cash And Equivalents | 30.94 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 6.01 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 2.96 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (8.5 M) | ||||
| Short Ratio | 4.53 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 4.2 | ||||
| Number Of Employees | 139 | ||||
| Beta | 1.38 | ||||
| Market Capitalization | 185.72 M | ||||
| Total Asset | 46.72 M | ||||
| Retained Earnings | (561.73 M) | ||||
| Working Capital | 4.84 M | ||||
| Current Asset | 17.14 M | ||||
| Current Liabilities | 16.14 M | ||||
| Net Asset | 46.72 M |
About Stereotaxis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stereotaxis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stereotaxis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stereotaxis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.